您当前的位置:
首页 >
文章列表页 >
Induction of anti-hepatoma immunity by recombinant retrovirus expressing B7-1 /B7-2 costimulatory molecules
更新时间:2026-03-12
    • Induction of anti-hepatoma immunity by recombinant retrovirus expressing B7-1 /B7-2 costimulatory molecules

    • Induction of anti-hepatoma immunity by recombinant retrovirus expressing B7-1 /B7-2 costimulatory molecules

    • 解放军医学杂志(英文版) 2000年0卷第2期 页码:138-142

    移动端阅览

  •  
  •  
  • HTML全文

  • 出版信息

  • 数据统计

论文导航
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

3

浏览量

22

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
  • BibTeX下载
  • Endnote下载
  • RefMan 下载
  • NoteExpress下载
  • NoteFirst下载

相关文章

Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research
Ionizable drug delivery systems for efficient and selective gene therapy
Novel gene therapy for rheumatoid arthritis with single local injection: adeno-associated virus-mediated delivery of A20/TNFAIP3
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies

相关作者

Xiao Yang
Jian Wang
Jing-Ping Xu
Jun Wang
Zhen-Hua Li
Wen-Zhen Du
Yu-Qi Zhang
Ran-Ran Guo

相关机构

Yaneng BIOScience (Shenzhen) Co., Ltd.
State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences, Beijing Institute of Lifeomics
Department of Health Technology and Informatics, the Hong Kong Polytechnic University
Department of Laboratory Medicine, Dongguan Institute of Clinical Cancer Research, Affiliated Dongguan Hospital, Southern Medical University
Advanced Research Institute of Multidisciplinary Science, School of Life Science, School of Medical Technology, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Beijing Institute of Technology